 "Pfizer posts Q3 net profit at Rs 64 cr")
The company had posted a net profit of Rs 48.28 crore for the corresponding period previous fiscal, Pfizer said in a filing to BSE.
Net sales of the company stood at Rs 229.78 crore for the quarter under consideration against Rs 251.88 crore for the year-ago period.
The company has transferred on December 7, 2012, it's 100% ownership in the wholly owned subsidiary Pfizer Animal Pharma Pvt Ltd to Pfizer Animal health India Ltd, a 100% indirect subsidiary of Pfizer Inc, for a consideration of Rs 471.60 crore, Pfizer said.
"The gain on sale of investment of Rs 3,160 lakh is disclosed as exceptional item for the current quarter," it added.
The sale of animal health business has been effective from April 2, 2012, therefore the figures of previous quarter are not comparable, Pfizer said.
In a separate filing to BSE, Pfizer said its board has accepted the resignation from board of its Executive Director Business Operations Sunil Madhok who retired from the services of the company with effect from January 31, 2013.
Shares of Pfizer were today trading at Rs 1,145.45 per scrip in the afternoon trade on BSE, up 0.76% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%